← Back to all trials
Active Not Recruiting
NCT03270982
Comprehensive Segmental Revision System
Conditions: Degenerative Disease, Oncology, Revision Surgery, Trauma, Rheumatoid Arthritis
Sex: All
Healthy volunteers: No
Enrollment: 105
Sponsor: Zimmer Biomet
Location: Nova Scotia Health Authority Halifax Nova Scotia
Summary
Clinical Data evaluation to document the performance and clinical outcomes of the Comprehensive Segmental Revision System.
Eligibility Criteria
Inclusion Criteria:
* Non Inflammatory Degenerative joint disease, including osteoarthritis, and avascular necrosis
* Rheumatoid arthritis
* Revision where other devices or treatments have failed
* Correction of functional deformity
* Oncology applications including bone loss due to tumour resection
Exclusion Criteria:
* Sepsis ( active)
* Infection ( active)
* Osteomyelitis (active)
Source: ClinicalTrials.gov (NCT03270982). StuddyBuddy aggregates publicly available trial information.
